Cyclosporine A (CsA) causes distal renal tubular acidosis (dRTA) in humans and rodents. Because mice deficient in nitricoxide (NO) synthase develop acidosis, we examined how NO production modulated H ϩ excretion during acid loading and CsA treatment in a rat model. Rats received CsA, L-arginine (L-Arg), or N -nitro-L-arginine methyl ester (L-NAME), or combinations of CsA and L-NAME or L-Arg, followed by NH 4 Cl (acute acid load). In vehicle-treated rats, NH 4 Cl loading reduced serum and urine (HCO 3 Ϫ ) and urine pH, which was associated with increases in serum [K ϩ ] and [Cl Ϫ ] and urine NH 3 excretion. Similar to CsA (7.5 mg/kg), L-NAME impaired H ϩ excretion of NH 4 Cl-loaded animals. The combination CsA and L-NAME reduced H ϩ excretion to a larger extent than either drug alone. In contrast, administration of L-Arg ameliorated the effect of CsA on H ϩ excretion. Urine pH after NH 4 Cl was 5.80 Ϯ 0.09, 6.11 Ϯ 0.13*, 6.37 Ϯ 0.16*, and 5.77 Ϯ 0.09 in the vehicle, CsA, CsA ϩ L-NAME and CsA ϩ L-Arg groups, respectively (*P Ͻ 0.05). The effect of CsA and alteration of NO synthesis were mediated at least in part by changes in bicarbonate absorption in perfused cortical collecting ducts. CsA or L-NAME reduced net HCO 3 Ϫ absorption, and, when combined, completely inhibited it. CsA ϩ L-Arg restored HCO 3 Ϫ absorption to near control levels. Administration of CsA along with L-NAME reduced NO production to below levels observed with either drug alone. These results suggest that CsA causes dRTA by inhibiting H ϩ pumps in the distal nephron. Inhibition of NO synthesis may be one of the mechanisms underlying the CsA effect.